28.06.2011
IMAP Pharma Report 2011
The Pharmaceutical industry is undergoing major fundamental transitions. Lack of new drugs and price pressure by the payer groups decrease margins. To seize opportunities provided by the emerging markets and new technologies,...
[more]
10.02.2011
KP Recognized Representative at SIX
In January 2011, Kurmann Partners was admitted as Recognized Representative at the leading Swiss stock exchange SIX Swiss Exchange on the grounds of the experience and expertise of Christoph Rentsch (see profile here) . We can...
[more]
04.09.2010
P. Degen joins KP
Peter Degen-Wick has extensive experience as senior executive in Pharma, OTC and personal care fast-moving consumer goods as well as deep knowledge of the Latin American and the European markets. Find more information in his...
[more]
